NCT06677333

Brief Summary

This study will determine the effect of dietary protein not absorbed in the small intestine on the bacteria in the large intestine and the metabolites those bacteria produce when they break down the protein. The three specific goals are:

  1. 1.Determine if increasing dietary protein increases the purine breakdown product, allantoin, as observed in our previous study.
  2. 2.Establish a model to examine the effect of dietary protein on the gut microbiota and metabolites.
  3. 3.Identify gut bacteria and metabolite changes that occur with increased consumption of animal (whey) or plant (pea) protein sources.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
87

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

November 4, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 6, 2024

Completed
Last Updated

November 6, 2024

Status Verified

September 1, 2024

Enrollment Period

10 months

First QC Date

November 4, 2024

Last Update Submit

November 5, 2024

Conditions

Keywords

gut microbiotadietary proteingut metabolitesgut metabolomedietary purinesgut microbiome

Outcome Measures

Primary Outcomes (1)

  • Fecal allantoin

    A cross-sectional study the investigators conducted found that healthy individuals who reported consuming, on average, 150 gms of protein daily had a higher fecal allantoin. This study is a pre/post-randomized controlled trial to confirm that observation. It will determine if consuming 50 gms more protein daily increases fecal allantoin.

    A fecal sample is collected before and after consuming a protein supplement (pea or whey) for seven days.

Secondary Outcomes (2)

  • Changes in fecal bacterial species before and after increasing dietary protein intake (pea or whey) by 50 grams for seven days

    A fecal sample is collected before and after consuming a protein supplement (pea or whey) for seven days.

  • Changes in fecal metabolites before and after increasing dietary protein intake (pea or whey) by 50 grams for seven days

    A fecal sample is collected before and after consuming a protein supplement (pea or whey) for seven days.

Study Arms (2)

Whey protein supplement

EXPERIMENTAL

This group of participants will consume 50 g of whey protein supplement daily.

Other: Whey Protein

Pea protein supplement

EXPERIMENTAL

This group of participants will consume 50 g of pea protein supplement daily.

Other: Pea protein

Interventions

This intervention will add 50 g of a whey or pea protein supplement to their usual dietary intake.

Whey protein supplement

This intervention will add 50 g of a pea protein supplement to their usual dietary intake.

Pea protein supplement

Eligibility Criteria

Age25 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old or older
  • male or female
  • located in the contiguous United States

You may not qualify if:

  • Taken any prebiotics in the last week
  • Taken any probiotics in the last week
  • Taken any prescription medications other than oral contraceptives
  • Taken antibiotics sometime in the last three months
  • Taken any diarrhea inhibitors in the last week
  • Taken any laxatives in the last week
  • Taken any dietary supplement(s)
  • Diagnosed with cancer
  • Diagnosed with an inflammatory disease of the GI tract, such as irritable bowel disease
  • Experienced long-haul COVID fatigue
  • Were physically inactive (\<600 METS per week)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Louisiana State University Health Sciences Center New Orleans

New Orleans, Louisiana, 70112, United States

Location

MeSH Terms

Interventions

Whey ProteinsPea Proteins

Intervention Hierarchy (Ancestors)

Milk ProteinsAnimal Proteins, DietaryDietary ProteinsProteinsAmino Acids, Peptides, and ProteinsWheyMilkDairy ProductsFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesPlant Proteins, DietaryPlant Proteins

Study Officials

  • Lauri O. Byerley, PhD

    APUS/LSUHSC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Participants will be randomized to consume 50 g of whey or pea protein for seven days.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 4, 2024

First Posted

November 6, 2024

Study Start

February 1, 2023

Primary Completion

November 30, 2023

Study Completion

November 30, 2023

Last Updated

November 6, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Data requests can be submitted six months after article publication. Qualified researchers engaged in independent scientific research can request access to this study's IPD, which will be provided following the review and approval of a research proposal, Statistical Analysis Plan (SAP), and execution of a Data Sharing Agreement (DSA). Data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis. For more information or to submit a request, please contact lbyerl@lsuhsc.edu.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data requests can be submitted six months after article publication and will be accessible for up to 24 months.
Access Criteria
Qualified researchers engaged in independent scientific research can request access to this study's IPD, which will be provided following the review and approval of a research proposal, Statistical Analysis Plan (SAP), and execution of a Data Sharing Agreement (DSA). D

Locations